arrow
P

Paul Cheng

stanford university school of medicine
H指数:31
被引数:5,350

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Aryl-hydrocarbon receptor in smooth muscle cells protects against dioxin-induced atherosclerosis

芳烃受体在平滑肌细胞中保护免受二噁英诱导的动脉粥样硬化

2026-09-240
OA
Vascular smooth muscle cell state trajectories mediate molecular mechanisms of coronary disease risk

血管平滑肌细胞状态轨迹介导冠状动脉疾病风险的分子机制

2026-03-170
OAAI
Targeting modulated vascular smooth muscle cells in atherosclerosis via FAP-directed immunotherapy

Amrute, J.M.; Jung, I.H.; Yamawaki, T.; Lin, W.L.; Bredemeyer, A.; Diekmann, J.; Hayat, S.; Zhang, X.; Wakefield, D.L.; Luo, X.; et al. 通过FAP定向免疫疗法靶向调节动脉粥样硬化中的血管平滑肌细胞。Science 2026, eadx1736. [Google Scholar] [CrossRef]

Science
IF45.8
2026-01-290
PRE
Osimertinib induces reversible cardiac dysfunction through the GATA4-MYLK3-MYL2 axis

奥希替尼通过GATA4-MYLK3-MYL2轴诱导可逆性心脏功能不全

2025-12-011
PRE
A cell and transcriptome atlas of human arterial vasculature

人类动脉血管的细胞与转录组图谱

2025-10-130
OAAI
Smooth muscle expression of RNA editing enzyme ADAR1 controls activation of the RNA sensor MDA5 in atherosclerosis

平滑肌细胞中RNA编辑酶ADAR1的表达调控动脉粥样硬化中RNA传感器MDA5的激活。

2025-09-160
OA
Cardiac Troponin Screening and Clinical Outcomes in Patients Receiving Immunotherapy

心肌肌钙蛋白筛查与接受免疫治疗患者的临床结局

2025-08-140
PREAI
Preclinical evaluation of high-resolution CT, 18F-FDG, and 18F-NaF PET imaging for longitudinal monitoring of atherosclerosis

高分辨率CT、18F-FDG和18F-NaF PET成像在动脉粥样硬化纵向监测中的临床前评估

2025-04-280
OA
Smooth muscle expression of RNA editing enzyme ADAR1 controls vascular integrity and progression of atherosclerosis

平滑肌细胞中RNA编辑酶ADAR1的表达调控血管完整性和动脉粥样硬化的进展

2024-11-120
PRE
Genetic and functional analysis of Raynaud's syndrome implicates loci in vasculature and immunity

雷诺综合征的遗传和功能分析与血管和免疫相关的基因座有关

2024-09-010
OAAI